- Asia health systems are diverse in their needs and pain points - Asia represents a significant opportunity for healthcare innovators - HealthTech is an unprecedented opportunity for Asia to transform patient outcomes - Asia’s HealthTech ecosystem is nascent but thriving - Galen Growth Asia is the healthtech catalyst in Asia

1. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
RESI 2017 Ÿ Asia HealthTech Landscape
10th January 2017 Ÿ San Francisco Ÿ Galen Growth Asia
Landscape
Asia HealthTech
@GalenGrowthAsia
#GGAJPMHC35

2. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
Julien de Salaberry
Co-founder & Managing Director
Galen Growth Asia: Asia’s HealthTech Connector!
julien.desalaberry@galengrowth.asia
@GalenGrowthAsia
www.galengrowth.asia
Founder & General Partner
The Global Cancer Research & Commercialization Fund
M: +65 9488 7334 Ÿ julien@gcrcfund.org
@GCRCF
www.gcrcfund.org
Galen Growth Asia is an independent
organization with the objective of
developing the healthtech ecosystem
across Asia Pacific through collaboration
between all interested stakeholders
The GCRCF is an impact investment
fund focused on fostering a collaboration
between leading research institutes and
relevant research foundations supported
with investment capital

3. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
• Asia health systems are diverse in their needs and pain points
• Asia represents a significant opportunity for healthcare innovators
• HealthTech is an unprecedented opportunity for Asia to transform patient
outcomes
• Asia’s HealthTech ecosystem is nascent but thriving
• Galen Growth Asia is the healthtech catalyst in Asia
Healthcare in Asia is changing dramatically

4. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
“For all emerging markets, the
conditions are very challenging. But
where we see challenges, I see
opportunity. In fact: our challenges
are your opportunities ”
— Joko Widodo —
President, Indonesia
Asia
HEALTHCARE

5. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
Asia Healthcare: A Tale of Two Regions
Mature Economies: Rising healthcare costs is an ongoing challenge
Developing Economies: Lack of healthcare access is a growing problem
Challenges in
Developed
Economies
Challenges in
Developing
Economies
Rising healthcare costs Ageing population
Lack of healthcare
access
Increasing chronic
disease prevalence
Lack of
infrastructure
Increasing chronic
disease prevalence

6. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
Asia Healthcare: Facing many healthcare challenges
1.1B people
50+ years of age by 2025
~3.7B people
51% of world’s population
lives in APAC
65M babies
Born each year (equivalent
to UK population size)
2B people
In consuming class by 2025
(~50% of whole of APAC)
2/3 global disease burden
For major chronic
respiratory diseases
Inadequate Infrastructure
India will take 85 yrs to achieve
OECD physician diversity
Regulatory Capability
China’s regulatory staff workload
20x relative to the US
Growing Value Pool
$1.8T spent on healthcare
in Asia
Affordability Levels
80% of developing APAC population
cannot afford solutions designed
for mature markets
Frugal Spending
Average healthcare spending
per capita
APAC
EU
US
$ 376
$ 4,018
$ 9,146
Source: McKinsey&Company, December 2015, Medtronic Analysis 2016

7. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
2B Asia Consumers by 2025: Seeking Choice & Value
Source: World Bank, Nielsen
% OOP: Private Expenditure on Health
% of Online Shoppers via smartphone
0
25
50
75
100
31%
Thailand
25%
S. Korea
23%
Philippines
21%
China
20%
Malaysia
18%
Singapore
18%
Vietnam
16%
Hong Kong
14%
Indonesia
10%
Taiwan
10%
USA
10%
Australia
7%
UK

8. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
Asia Healthcare: Six Key Inefficiencies
Source: Galen Growth Asia & sponsors analysis - 2016
• Further compounding these daunting
healthcare challenges is the
inefficient way healthcare gets
delivered in these markets
• GGA has identified six significant
forms of inefficiencies which are
ubiquitous in these health systems
• The net effect of having these
inefficiencies is that they undermine
the significant public and private
capital being deployed in these
markets to drive meaningful societal
and healthcare impact
• Each category represents a
significant opportunity for healthcare
innovators

9. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
“The biggest innovations in the
world will come from the
intersection of bio & tech”
— Susan Desmond-Hellmann —
Chief Executive Officer - Bill & Melinda
Gates Foundation
Healthtech
In Asia

10. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
HealthTech: Asia Startups Landscape
Nascent But Thriving Ecosystem
HealthTech Startups by Category HealthTech Startups by Country
Note: WIP as at Dec 2016
Source: Galen Growth Asia
Medical Data & Analytics
4%
Genomics
3%
Consumer Health &
Wellness
20%
Navigating the
Healthcare System
21%
Patient
Engagement
17%
HCP Management
14%
Sensors &
Diagnostics
16%
Telehealth &
Remote Monitoring
5%
Australia & NZ
9%
Indonesia
5%
Singapore
14%
Malaysia
3%
India
44%
Philipines
3%
Vietnam
2%
China & HK
10%
South Korea
3%
Thailand
1%
Japan
5%
Taiwan
1%

11. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
Venture Funding: Asia Funding Trends
Noteworthy Funding Rounds 2015 & 2016
Target Category
Funding Size
($M) & Stage
Principal
Investor(s)
Ping An Good Doctor (CH)
Navigating The
Healthcare System
500.0
Series A
• Ping An
GuaHao (CH)
Navigating the
Healthcare System
394.0
Series D
• Tencent
• Hillhouse
Capital
• Goldman Sachs
Practo (IN)
Navigating the
Healthcare System
90.0
Series C
• Tencent
• Google
• Sequoia
Portea Medical (IN)
Sensors &
Diagnostics
37.5
Series B
• Qualcomm
• IFC
• Accel Partners
1MG (IN)
Consumer Health &
Wellness
20.0
Series B
• Sequoia Capital
• Intel Capital
HaloDoc (INDO)
Navigating the
Healthcare System
13.0
Series A
• NSI
• Clermont Group
Target Category
Funding Size
($M) & Stage
Principal
Investor(s)
Attune Technologies (IN)
HCP Management 10.0
Series B
• Qualcomm
• Norwest
Prenetics (HK)
Genomics 10.0
Series A
• Ping An
DocDoc (SG)
Navigating the
Healthcare System
8.5
Series A
• Yee How
Choong
• SparkLabs
ConnexiosnAsia (SG)
Navigating the
Healthcare System
8.0
Series A
• NSI
• BioVeda
Stasis Lab (IN)
Telehealth & Remote
Monitoring
5.0
Series A
• Techstars
• RTP Ventures
Health2Sync (TW)
Patient Engagement 3.0
Series A
• WI Harper Gp
• Cherubic
Ventures
Note: WIP as at Dec 2016
Source: Galen Growth Asia, Media
2016
2015
2015
2015
2016
2016
2016
2016
2015
2015
2016
2016

12. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
“A system in which competition,
territorialism and “stove-piping” of
information leaves researchers and
their discoveries cloistered in their
own corners”
— Joe Biden —
US Vice President
Building
Our Ecosystem

13. ©2017 by Galen Growth Asia - All rights reserved. Proprietary and Confidential.
• Our mission is to develop the healthtech ecosystem across
Asia through collaboration between stakeholders groups
• Founded by healthtech entrepreneurs, investors and advisors
committed to the vertical
• The Asia Healthtech Connector through its unique events,
rich content and co-building the much needed ecosystem
enablers
• We have launched first of their kind ventures such as our
startups database and CEO Summit
Galen Growth Asia: The Asia HealthTech Connector

14. Thought Leadership Networking Breakout Sessions
VIP Speakers Data & Research Reports